StimLabs

StimLabs has commercialized a suite of advanced wound care products derived from human placental tissues, including dehydrated human umbilical cord particulate devices and complete human placental membrane allografts. These products are used in both office-based and hospital-based settings for complex wound management, surgical reconstruction, and as barriers in gynecological procedures. The company holds a growing intellectual property portfolio with at least thirteen patents granted or filed related to developmental biology, stem cells, embryology, midwifery, and obstetrics.[1][3][4][6] Clinical testimonials highlight positive outcomes in chronic wounds and post-surgical healing.[2] There are no published results from formal clinical trials found in the provided sources.